The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)
Clinical trial NCT02273713 · COMPLETED
Trial details
- NCT number
- NCT02273713
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2017-03-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.